Related Experiment Video
Updated: Jul 7, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Stroke pathophysiology: management challenges and new treatment advances
J Jordán1, I Ikuta, J García-García
1Departamento de Ciencias Médicas, Facultad de Medicina, Universidad Castilla-La Mancha, Spain. joaquin.jordan@uclm.es
Journal of Physiology and Biochemistry
|March 4, 2008
Summary
Acute ischemic stroke management is evolving with thrombolytic therapy and specialized Stroke Units. Despite promising preclinical data, neuroprotective drugs have faced challenges in clinical trials for stroke treatment.
Area of Science:
- Neurology
- Emergency Medicine
- Pharmacology
Background:
- Stroke is a leading cause of death and disability globally.
- Thrombolytic therapy, like rtPA, is now standard for acute ischemic stroke within 3 hours.
- Stroke Units improve acute stroke care through physiological monitoring.
Purpose of the Study:
- To review the pathophysiology of acute ischemic stroke.
- To discuss current management challenges and advances.
- To explore pharmacological targets and reasons for clinical trial failures.
Main Methods:
- Literature review focusing on acute ischemic stroke management.
- Analysis of pathophysiology and therapeutic strategies.
- Integration of preclinical and clinical trial data.
Main Results:
- rtPA is effective within 3 hours, with FDA and EMEA approval.
- Neuroprotective therapies show promise in preclinical studies but have largely failed in clinical trials.
- New treatment strategies are under development.
Conclusions:
- Understanding acute ischemic stroke pathophysiology is crucial for effective management.
- Clinical trial failures may stem from inadequate preclinical testing or flawed development.
- Further research is needed to overcome challenges in developing successful neuroprotective treatments for stroke.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...